According to a meta-analysis, which had a total of 1192 patients and assessed five types of cancer, the high-expression of USP7 may promote the progression of epithelial ovarian cancer (EOC) and predict unfavorable prognosis of EOC patients (51). This evidence concerns the gene USP7 and cancer.